mycoplasma
pneumonia
pneumonia
mp
common
human
respiratori
tract
pathogen
caus
communityacquir
pneumonia
cap
case
adult
world
especi
china
incid
sinc
clinic
laboratori
manifest
differenti
pneumonia
caus
typic
atyp
pathogen
commonli
describ
effect
pneumonia
lack
cell
wall
adequ
laboratori
diagnosi
pneumonia
pneumonia
import
diagnosi
pneumonia
infect
routin
clinic
practic
base
serolog
cultur
polymeras
chain
reaction
pcr
among
pair
sera
show
fourfold
increas
igg
antibodi
titer
consid
reliabl
method
diagnosi
current
pneumonia
infect
howev
difficulti
obtain
convalesc
serum
time
constraint
igg
antibodi
titer
test
pair
sera
epidemiolog
rather
diagnost
tool
cultur
organ
slow
correl
cultur
infect
tenuou
asymptomat
infect
caus
pneumonia
detect
igm
antibodi
titer
acut
stage
serum
fluoresc
quantit
pcr
fqpcr
throat
swab
faster
techniqu
direct
comparison
pair
sera
result
three
assay
especi
fqpcr
kit
approv
state
food
drug
administr
china
made
studi
base
beij
network
adult
communityacquir
pneumonia
consist
teach
hospit
beij
evalu
accuraci
igm
serolog
fqpcr
cultur
earli
diagnosi
cap
caus
pneumonia
fourfold
greater
increas
igg
antibodi
titer
pair
sera
gold
standard
prospect
studi
conduct
teach
hospit
beij
chaoyang
hospit
beij
haidian
hospit
yantai
yu
huangd
hospit
peke
univers
peopl
hospit
luhe
teach
hospit
capit
medic
univers
wangj
hospit
china
academi
chines
medic
scienc
peke
union
medic
colleg
hospit
chinajapan
friendship
hospit
beij
friendship
hospit
beij
pinggu
hospit
huairou
first
hospit
air
forc
gener
hospit
pla
beij
china
octob
septemb
adult
adolesc
patient
year
age
radiograph
confirm
cap
enrol
consecut
pneumonia
detect
central
laboratori
clinic
microbiolog
laboratori
beij
chaoyang
hospit
patient
immunosuppress
receiv
immunosuppress
therapi
exclud
addit
pregnant
lactat
mother
patient
nurs
home
patient
whose
onset
time
longer
day
patient
admit
hospit
longer
day
within
last
day
also
exclud
clinic
featur
includ
comorbid
diabet
heart
diseas
cerebr
vascular
diseas
chronic
lung
renal
diseas
laboratori
data
record
data
sheet
enter
comput
databas
patient
enrol
studi
approv
institut
review
board
beij
chaoyang
hospit
written
inform
consent
provid
adult
parent
patient
age
less
year
throat
swab
first
serum
sampl
obtain
admiss
convalesc
serum
sampl
obtain
week
later
throat
swab
perform
ml
transport
broth
medium
oxoid
specimen
store
transport
ice
laboratori
within
week
pneumonia
cultur
throat
swab
specimen
vortex
supplement
amphotericin
b
penicillin
inocul
medium
medium
incub
observ
daili
week
decreas
ph
red
yellow
color
chang
posit
cultur
confirm
pcr
assay
previous
report
dna
extract
throat
swab
sampl
manual
nucleic
acid
extract
qiagen
qiamp
dna
mini
kit
valencia
ca
pneumonia
detect
commerci
fqpcr
kit
daan
gene
guangzhou
china
approv
state
food
drug
administr
target
ribosom
rna
gene
genbank
fqpcr
mixtur
prepar
total
volum
contain
sampl
dna
fqpcr
perform
follow
condit
initi
activ
min
follow
cycl
min
cycl
result
display
qualit
intern
control
target
human
ribonucleas
protein
hrnp
gene
incorpor
amplif
perform
use
ab
real
time
pcr
system
appli
biosystem
foster
citi
ca
accord
manufactur
instruct
specimen
quantit
test
igg
igm
antibodi
pneumonia
use
virionserion
elisa
kit
gmbh
germani
antibodi
activ
given
uml
base
manufactur
recommend
mp
igg
calcul
interpret
follow
posit
result
uml
borderlin
result
uml
neg
result
uml
igm
posit
result
uml
borderlin
result
uml
neg
result
uml
elisa
reaction
perform
accord
manufactur
instruct
thermo
multiskan
thermo
fisher
scientif
waltham
system
technician
microbiolog
examin
also
perform
throat
swab
sputum
urin
blood
etiolog
consid
definit
one
follow
criteria
met
posit
bacteri
cultur
posit
urinari
antigen
l
pneumophila
binax
l
pneumophila
urinari
antigen
test
triniti
biotech
bray
ireland
posit
urinari
antigen
pneumonia
binax
pneumonia
urinari
antigen
test
emergo
europ
netherland
detect
respiratori
virus
rtpcr
use
seeplex
rv
detect
kit
seegen
biotechnolog
inc
seoul
korea
includ
respiratori
syncyti
viru
b
influenza
viru
ifv
b
parainfluenza
viru
piv
human
rhinoviru
hrv
enteroviru
human
coronaviru
human
metapneumoviru
hmpv
adenoviru
adv
human
bocaviru
comparison
clinic
characterist
clinic
outcom
conduct
patient
pneumonia
posit
neg
group
use
unpair
student
ttest
test
chisquar
test
spss
window
pvalu
consid
statist
signific
sensit
specif
predict
valu
determin
standard
procedur
clinic
diagnost
valu
differ
test
evalu
likelihood
ratio
strong
evid
rule
diagnos
circumst
posit
likelihood
ratio
prospect
studi
cap
patient
pair
sera
meet
inclus
criteria
enrol
male
femal
patient
age
rang
year
median
year
see
tabl
overal
acut
pneumonia
infect
diagnos
patient
show
fourfold
greater
increas
igg
antibodi
titer
pair
sera
twentythre
patient
caus
pathogen
pneumonia
among
patient
one
posit
piv
type
ifva
one
posit
ifva
pseudomona
aeruginosa
one
posit
ifva
klebsiella
pneumonia
nine
posit
ifva
three
posit
adenoviru
three
posit
piv
type
one
posit
hmpv
one
posit
hrv
one
posit
piv
type
one
posit
piv
type
patient
posit
pneumonia
median
age
year
rang
year
significantli
younger
pneumoniaeneg
patient
rang
year
p
pneumonia
infect
less
like
comorbid
p
differ
smoke
statu
two
group
similar
distribut
symptom
found
group
admiss
except
durat
fever
admiss
longer
group
pneumonia
infect
group
without
p
group
pneumonia
infect
higher
mean
heart
rate
p
two
group
similar
pattern
biochem
haematolog
find
differ
use
antibiot
treatment
statu
day
onset
igm
test
two
group
result
igm
test
fqpcr
cultur
compar
see
tabl
pneumonia
posit
rate
evalu
igm
antibodi
test
acut
stage
serum
fqpcr
cultur
lower
result
pair
sera
among
patient
posit
pneumonia
two
found
posit
igm
antibodi
test
fqpcr
cultur
nonm
pneumonia
infect
test
fqpcr
hrnp
gene
success
amplifi
data
shown
among
discord
result
eight
patient
show
fourfold
greater
increas
igg
titer
neg
result
three
method
fifteen
patient
neg
pair
sera
posit
method
among
four
posit
fqpcr
cultur
one
posit
fqpcr
igm
test
one
posit
cultur
igm
test
six
posit
fqpcr
three
posit
igm
test
evalu
japanes
respiratori
societi
jr
score
system
patient
posit
pair
sera
patient
neg
pair
sera
score
use
pair
sera
show
fourfold
greater
increas
igg
antibodi
titer
gold
standard
diagnost
paramet
three
method
evalu
see
tabl
includ
sensit
specif
posit
neg
predict
valu
ppv
npv
respect
posit
likelihood
ratio
plr
specif
npv
three
method
high
around
specif
around
npv
similarli
increas
trend
sensit
ppv
plr
lowest
igm
antibodi
test
respect
intermedi
fqpcr
respect
highest
cultur
respect
result
show
pneumonia
import
pathogen
adolesc
adult
cap
patient
consist
find
capnetz
report
present
studi
also
demonstr
compar
nonmycoplasma
infect
cap
patient
infect
pneumonia
younger
less
like
comorbid
longer
durat
fever
admiss
infect
pneumonia
igm
antibodi
appear
first
week
ill
reach
peak
titer
third
week
et
al
found
sensit
igm
assay
diagnosi
acut
pneumonia
infect
adult
cap
patient
studi
howev
sensit
igm
assay
compar
fourfold
increas
igg
titer
adult
patient
antibodi
constantli
neg
produc
day
onset
result
multipl
previou
infect
therefor
use
igm
assay
sole
test
may
provid
inadequ
inform
compar
pcr
sensit
cultur
respiratori
specimen
turn
low
similarli
et
al
report
cultur
unaccept
insensit
diagnos
pneumonia
infect
studi
howev
differ
posit
rate
two
method
wari
et
al
found
children
furthermor
valu
diagnost
paramet
includ
specif
sensit
posit
neg
predict
valu
posit
likelihood
ratio
highest
among
three
method
evalu
particular
plr
mean
reason
correl
cultur
result
true
infect
howev
prolong
turnaround
time
limit
clinic
applic
cultur
compar
serolog
cultur
pcr
especi
realtim
pcr
rapid
practic
sensit
suggest
suitabl
earli
diagnosi
acut
pneumonia
infect
touati
et
al
evalu
five
commerci
kit
base
pcr
found
sensit
kit
similarli
et
al
observ
sensit
specif
ppv
npv
pcr
respect
present
studi
howev
sensit
specif
ppv
npv
fqpcr
kit
target
rrna
gene
respect
low
sensit
pcr
test
may
due
low
bacteri
load
result
previou
antimicrobi
treatment
dilut
sampl
throat
swab
limit
detect
detect
limit
fqpcr
kit
state
copi
per
manual
lower
copi
per
commerci
kit
report
addit
found
effici
pcr
assay
could
influenc
sampl
type
sputum
could
superior
respiratori
sampl
includ
throat
swab
possibl
reason
contribut
discord
result
fqpcr
cultur
igg
serolog
explor
four
patient
one
posit
fqpcr
cultur
three
posit
fqpcr
might
repres
asymptomat
carriag
pneumonia
result
persist
previou
infect
sinc
patient
respect
cap
etiolog
identifi
ifva
hmpv
adv
hrv
five
patient
three
posit
fqpcr
cultur
two
posit
fqpcr
cultur
igm
test
show
fold
increas
igg
respons
could
explain
inadequ
time
interv
mean
interv
day
remain
three
patient
posit
fqpcr
year
old
fail
develop
igg
antibodi
respons
pair
sera
could
interpret
deterior
immun
respons
due
age
case
highlight
limit
serolog
diagnosi
could
affect
time
specimen
collect
age
patient
recent
china
yin
et
al
demonstr
good
sensit
specif
jr
score
system
earli
presumpt
diagnosi
pneumonia
pneumonia
cohort
show
fourfold
greater
increas
igg
antibodi
titer
pair
sera
gold
standard
sensit
specif
jr
score
respect
posit
either
pcr
cultur
igm
fourfold
increas
igg
diagnosi
pneumonia
pneumonia
sensit
decreas
specif
increas
limit
studi
includ
cost
consider
evalu
one
fqpcr
kit
approv
state
food
drug
administr
china
patient
receiv
antibiot
includ
macrolid
fluoroquinolon
posit
rate
cultur
fqpcr
may
decreas
studi
approv
beij
chaoyang
hospit
ethic
committe
written
inform
consent
provid
adult
parent
patient
age
less
year
author
declar
compet
interest
qjx
carri
laboratori
test
perform
statist
analysi
particip
design
coordin
studi
draft
manuscript
gl
wj
djp
pzh
gy
hm
zyx
gf
particip
enrol
cap
patient
record
demograph
inform
cb
wc
particip
design
coordin
studi
help
draft
manuscript
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
